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Introduction:  An  alarming  rise  of  obesity  in adolescents  has been  observed,  placing  them  at  risk
of developing  resistance  to  insulin  (IR)  and  its  adverse  metabolic  consequences  such  as  diabetes
mellitus type  2  (DM2),  metabolic  syndrome  and  cardiovascular  disease.
Objective:  To  know  the  prevalence  of  obesity,  and  the  levels  of  glucose,  insulin  and  HOMA-IR
and its  association  with  the  BMIz,  waist  circumference  and  the  pubertal  stage  in  a  random
sample of  adolescents.
Materials  and  methods: 292  adolescents  between  12  and 15  years  (152  female  and  140  male),
whose anthropometric  measurements  (weight,  height  and  waist  circumference)  were  taken,
body  mass  index  calculated  and  Z-score  determined.  Blood  glucose  and  insulin  levels  were
evaluated  from  a  sample  of blood  and  their  HOMA-IR  was  determined.
Results: The  results  showed  that  32.5%  were  obese,  22.3%  were  overweight  and  23.6%
showed adolescent  central  obesity.  Glucose  levels  (p  =  0.016),  insulin  (p  = 0.0001)  and  HOMA-IR
(p =  0.0001)  showed  significant  differences  in  the group with  obesity.  Values  of the  three  param-
eters were  increased  with  the  stage  of  puberty.  We  found  significant  differences  in  the  levels
of glucose  (p  = 0.0388),  insulin  (p  =  0.0005)  and  HOMA-IR  (p  =  0.0001)  between  the  prepubertal
and postpubertal  stages.
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Conclusion:  The  results  showed  that  the  presence  of  central  obesity,  overweightness  and  obe-
sity are  closely  associated  with  the  prevalence  of  IR,  and  may  be  significant  predictors  of
DM2.
© 2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma
México S.A.  This  is  an  open access  article  under  the  CC BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Obesity  in  children  and  adolescents  is an international
health  problem.  The  relationship  between  it  and  the devel-
opment  of  metabolic  alterations  like  insulin  resistance  (IR),
Diabetes  Mellitus  type  2  (DM2),  dyslipidemias  and cardio-
vascular  diseases  (CVD)  is  well  known. In the  IR  stage,
a  compensating  increase  of insulin  is  produced,  with  the
objective  of  maintaining  the homeostasis  of  glucose  (GL).
This  stage  of  chronic  hyperinsulinemia,  in  the  long  term,
leads  to  the  development  of  DM2,  metabolic  syndrome  (MS)
and  CVD.1--6 Obesity  with  an excess  of  adipose  tissue,  mainly
visceral,  creates  a  determining  factor  in  the  establishment
of  IR,  since  this  tissue,  in addition  to  fulfilling  its  duties
of  energetic  storage,  exercises  other  activities  involved
in  homeostatic  maintenance.  The  visceral  adipose  tissue
presents  a greater  amount  of  adrenergic  beta  receptors  than
the  subcutaneous  tissue,  significantly  favoring  the  lipolytic
activity  in  this  zone  of  the adipose  tissue,  generating  a larger
output  of  free  fatty  acids  toward the  portal  circulation  and
liver,  contributing  to  the establishment  of  insulin  resistance
in  hepatic,  muscular  and  pancreatic  tissue.  Additionally,  the
adipose  tissue  produces  pro-inflammatory  cytokines  such as
adipokines,  among  which  are  interleukin-6  (IL-6)  and  tumor
necrosis  factor  alpha  (TNF-)  which blocks  the cascade  of
insulin  signaling  (INS).  IL-6  and  TNF- promote  lipolysis  in
adipose  tissue,  favoring  portal  circulation  which floods  the
liver  and  other  tissues  with  more  free  fatty  acids,  which
contributes  to  RI.7--10 INS sensitivity  varies  in the  differ-
ent  stages  from childhood  to  adolescence.  In children  and
adolescents,  RI is  the  key  element  in MS associated  with
obesity,  and it  is  usually  present  for many  years  before  the
onset  of  abnormalities  like GL  intolerance,  dyslipidemia,
hypertension,  DM2  and CVD.11--13 In  Mexico,  according  to
the  National  Survey  of  Health  and  Nutrition  2012  (ENSANUT
by  its  Spanish  acronym),  the  combined  prevalence  of  over-
weightness  and obesity  in adolescents  between  12  and 19
years  of  age  is 35%,  35.8%  (3 175  711)  for females  and
34.1%  (3  148  146)  for  males.14 The  HOMA  index  (Homeostatic
Model  Assessment),  built  by  Matthews  (HOMA-IR),  is  the
most  utilized  method  to  determine  IR.15--19 Nationally  and
internationally,  there  is  no  consensus  related  to  the average
values  of  INS  and HOMA-IR  in children  and healthy  ado-
lescents,  thus  causing  researchers  to  establish  non-uniform
criteria  and  take  previously  conducted  studies  in  different
populations  as  a reference.  INS levels  in  eutrophic  chil-
dren  and  adolescents  have  been reported  by  Viso  et al.
(2004)  to  be 5.47  ±  2.46  UI/mL.20 Morales  et  al.  (2007)
reported  6.15  ±  1.97  UI/mL,21 Souki-Rincón  et al. reported
13.0  ± 0.5  UI/mL22 and  Marcos-Daccarett  et al. reported
7.0 ±  3.9  UI/mL.23 Goran  and  Gower,  after  insulinemia
measurement  studies  in  the  pubertal  stage,  established
some  cut  points.  They  determined  for  the  prepubertal  stage
(Tanner  1  stage)  insulinemia  values  ≥15  UI/mL,  for  middle
prepubertal  (Tanner  2--4  stage)  values  ≥30 UI/m,  and  post-
pubertal  (Tanner  4--5  stage)  values  of  ≥  a  20  UI/mL.24 Other
researchers  determined  their  own  cut  levels  for  their  respec-
tive  areas  of study, estimating  tables  with  percentiles.
However,  the  lack  of  these  tables  in an  important  group  of
countries  for  pediatric  ages  prevents  uniform  criteria  from
being  established.11,25 The  same  situation  occurs  for  the  cut
point  in IR diagnosis.  In 2005  Kinski  et  al.  reported  HOMA-IR
>3.16  and  Hirschler  et  al. reported  it as  >3.29.26,27 Anthro-
pometry  is  used in  order  to evaluate the degree  of  obesity,
like  the body mass  index  (BMI) calculating  its Z score  (BMIz)
and  the measurement  of  the  circumference  of  the waist
(CW).3,28--30 Therefore,  the objective  of the present  inves-
tigation  was  to know  the  prevalence  of  OW,  OB  and  COB,  GL
and  INS levels, HOMA-IR  and  its connection  to  BMIz,  CW  and
the pubertal  stage  in adolescents  between  12  and  15  years
of  age  in Saltillo,  Coahuila,  Mexico.
Materials and methods
The  present  investigation  is  descriptive/transversal.  A  total
of  292  adolescents  were  randomly  analyzed  between  2012
and  2013  from  5  public  junior  high  schools  of  Saltillo,
Coahuila,  Mexico,  with  ages  ranging  between  12  and 15,
who  participated  voluntarily  with  an informed  consent
signed  by  their  parents  or  tutors. Adolescents  who  suffered
from  any  sort of systemic  or  endocrinological  chronic  dis-
ease  were  excluded  because  they  could  alter  the  analytic
results.  Physical  and anthropometric  exams  were  performed
in  order  to  determine  their  nutritional  stage  and  puber-
tal  stage,  according  to  Marshall  and  Tanner.31,32 Regarding
anthropometric  measurements,  size was  measured  using  the
stadimeter  (206  SECA  BODYMETER,  SECA  AYN.  Germany)  in
a  standing  position,  with  their  backs  toward  the  front,  bare-
foot,  and  the measurement  was  registered  in centimeters.
The  measurement  of  weight  was  performed  using  a  digi-
tal  scale  with  a capacity  of 150  kg  (Tanita  TFB  300,  Tanita
Corporation,  Arlington  Heights,  IL,  60005,  USA)  with  the
minimum  amount  of  clothing  on,  without  shoes,  registered
in  kilograms  and grams.  The  circumference  of  the  waist
was  performed  with  an anthropometric  flexible,  inextensi-
ble  tape (Lufkin  W606PM  Lufkin, USA),  with  the adolescent
in  a  standing  position,  arms  relaxed  on  the side  of  the  body,
measurement  in the middle  point  between  the costal  edge
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Table  1  Adolescents  classified  by  BMIz  in general  and  by  gender  Saltillo,  Coahuila,  Mexico  (2012--2013).
Gender  Total  Low  weight  Normal  weight  Overweight  Obese  Morbidly  obese
n  %  n  % n  %  n  %  n  %  n  %
General  292 100  22  7.5 110  37.7  65  22.3  78  26.7  17  5.8
Female 152 52  14  9.2 59  38.8  32  21.1  40  26.3  7  4.6
Male 140 48  8 5.7 51  36.4  33  23.6  38  27.2  10  7.1
and  the  iliac  crest,  breathing  out,  and considering  the cutoff
point  >90  percentile  for central  obesity.33 Moreover,  BMI  was
calculated  using  the  formula  weight/height2 and the  Z  score
was  evaluated  (BMIz)  in  order  to  classify  their  nutritional
state  using  the charts  of the  WHO.  The  Z score  is  expressed
in  units  of standard  deviation  (SD); a  Z  score  between  −2
and  −3  SD corresponds  to  severe  low weight,  between  −1
and  −2  SD  corresponds  to  low  weight,  between  +1 and  −1
SD  corresponds  to normal  weight,  between  +1  and  +1  SD
corresponds  to  overweight,  between  +2  and  +3  SD  corre-
sponds  to  obesity  and  greater  than  +3  SD  corresponds  to
morbid  obesity.34 Blood  was  obtained  via venous  puncture
with  a  previous  fasting of at least 12  h.  The  samples  were
centrifuged  at  35  000  rpm for 15  min  in refrigerated  cen-
trifuge  at  6 ◦C  (Thermo  Scientific  SL,  16R,  USA);  the  serum
was  conserved  at 4 ◦C up  to  the moment  of  processing  of
the  GL  on  the  same  day  as  extraction.  An  aliquot  was  pre-
served  at  −21 ◦C  for two  days  to  perform  the  INS  analysis.
The  determination  of  the GL  was  conducted  in automatized
‘‘Diconex’’  equipment  InCCA  (Intelligent  Clinical  Chemistry
Analyzer)  (Diconex,  USA)  through  the  enzymatic  method
(conversion  to  gluconate-6-phosphate  by hexokinase  and
glucose-6-phosphate-dehydrogenase  in  presence  of  ATP  and
NAD)  with  Human  reactives.
INS  analysis  was  made  with  the automated  equipment
TOSOH  AIA-600  (Tokyo,  Japan)  by  an  IFALS  (Immunofluo-
rescence  assay  with  labeled  substrate)  immunoassay  with
TOSOH  reactives.  We  used  high-  and  low-level  commercial-
grade  controls  (Human  brand)  in  both  tests.  The  index  of  the
homeostatic  model  was  calculated  with  the  Matthews  for-
mula:  HOMA  =  [Glucose  (mmol/L)  ×  Insulin  (U/mL)/22.5].
We  used  the FID  criteria  for  the fasting  GL  cutoff  point
value  ≥100  mg/dL,35 and  for  the fasting  INS  for  the  pre-
pubertal  state  insulinemia  values  of ≥15  UI/mL,  for  the
middle  pubertal  ≥30  mU/mL  and  for the postpubertal
≥20  mU/mL.24 We  considered  that  the  level  of RI that pre-
dicts  a  greater  rick  of DM-2  was  HOMA-IR  ≥3.16.26 The  results
were  expressed  as  an average,  standard  deviation  (SD)  and
the  analysis  of  the  variables  with  the number  of  cases  and  a
percentage.  We  compared  the average  between  the groups
with  the  Student’s  t  test;  for  more  than  2 groups  and  the
comparison  of  multiples  groups,  we  employed  the variation
analysis  (ANOVA,  test  by  Tukey).  The  results  were  considered
statistically  significant  with  a value  of  p ≤  0.05.  The  pre-
dictability  of  the AUS to  evaluate  the  efficacy  of  the  HOMA-IR
index  as  an  indicator  of  IR was  determined  by  the analysis
of  the  ROCC  (Receiver  Operating  Characteristic  Curve)  for
cutoff  values  of  3.16.  The  Minitab  16,  GrapPad  Prism  5 and
SPSS  21  programs  were used to  make  the statistical  analysis
of  the  results.
Results
Out  of  the  292 analyzed  adolescents,  52%  were  women  (152)
and  48%  were  men  (140),  with  a  mean  age  of  13.02  ±  0.94
years,  a mean  weight  of  60.02 ±  15.69  kg (27.2--120.3)  and  a
mean  size  of 158.34  ±  8.03  cm  (125--179).  The  prevalence  of
central  obesity  (percentile  >90)  was  at  23.6%  corresponding
to  49.3%  for  females  and  50.7%  for males.  According  to  their
BMIz,  over  half  of the  adolescents  presented  overweight-
ness  and obesity,  this  abnormality  being  more  predominant
in  males  (Table  1).
The mean  values  obtained  by  the  biochemical  param-
eters  in our  general  sample  were the  following:  GL
85.8  ±  11.8  mg/dL,  the percentage  above  ≥100 was  11.5%,
INS level was  13.2  ±  10.5  UI/mL  and  the HOMA-IR  value
was  2.9  ±  2.5 with  a 46%  over  ≥3.16.  When  analyzing
the results  by  gender,  we found that  for females,  GL
was  83.4  ±  11.2  mg/dL,  INS 13.4  ±  10.2  UI/mL and  HOMA-
IR  2.9 ±  2.5, while  for  males,  GL  was  88.5  ±  11.8  mg/dL,
INS 12.9  ±  10.8  UI/mL  and  HOMA-IR  2.9 ±  2.5.  We  found
statistically  significant  differences  between  genders  for
GL  (p  = 0.0002)  but  not for  INS  (p  = 0.6582)  and HOMA-IR
(p  = 0.9965).  After  studying  the  results  of  the biochemical
parameters  concerning  BMIz,  we  noticed  that  the values
increased  as  BMIz  did,  presenting  the  highest  values  in OB
(Table 2). After  evaluating  HOMA-IR  results,  we  found  it
notoriously  high  in OB  (p  ≤ 0.0001).  There  were  statistically
significant  differences  in  GL (p  =  0.0161),  INS (p ≤  0.0001)
and  HOMA-IR  levels  (p  ≤  0.0001)  between  the  different  BMIz
groups.
After  examining  the  results  of  three  biochemical  param-
eters  by  gender  and  BMIz,  it was  noted  that  the  percentage
of  the highest  values  was  observed  in  the  OW  and  OB of
both  genders.  We  noticed  statistically  significant  differences
between  genders  with  OW  regarding  GL  levels  (p = 0.0046)
and  none in INS levels  (p  =  0.3006)  or  the  HOMA-IR  value
(p  = 0.1015).  Regarding  OB,  no  statistically  significant  differ-
ences  between  genders  were  observed  for  GL  (p = 0.0551),
INS (p  =  0.3150)  and  HOMA-IR  levels  (p  = 0.6537).
After  analyzing  the  results  of  the  three  parameters  in
relationship  with  pubertal  development,  it was  observed
that  the values  increased  when pubertal  development  was
raised  (Table 3).  There  was  a  statistically  significant  dif-
ference  between  the  prepubertal  and  the  postpubertal  in
relationship  with  GL  levels  (p  = 0.0247),  but  not in  INS
(p  = 0.4398)  or  HOMA-IR  (p  = 0.2255).  HOMA-IR  values  showed
that  approximately  half  the studied  adolescents  (pubertal
and  postpubertal)  presented  IR.
The  study  of  the results  of  the biochemical  parameters
regarding  pubertal  development  by  gender  revealed  that
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Table  2  Glucose,  insulin  and  HOMA-IR  by  BMIz  Saltillo,  Coahuila,  Mexico  (2012--2013).
BMIz  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  × mmol/L)
n Average  %a p  Averge  p  Average  %a p
(42--121)  (2,3--91.6)  (0,3--20,3)
Low  weight 22  82.5  ± 9.50  3.4  0.0271  6.4  ±  3.0  <0.0001  1.3 ± 0.6  0.04  <0.0001
Normal weight 110  85.2  ± 11.8 10.6 0.0367 8.0  ±  4.0  <0.0001  1.8 ± 1.3  10.7  <0.0001
Overweight  65  83.7  ± 10.6 6.4 0.0081 11.5  ±  5.7 <0.0001  2.4 ± 1.3  21.4  <0.0001
Obese 95  88.8  ± 12.4  18.5  0.0161* 21.9  ±  13.2  <0.0001* 4.9 ± 3.1  66.9  <0.0001*
a % of values above the cutoff point. Cutoff points: Glucose ≥100 mg/dL; insulin: was not  evaluated, there are no cutoff points for this
biochemical parameter in relation to BMI; HOMA-IR ≥3.16. For the value of p we collated all the IMCz against that of Obesity (t-Student).
* ANOVA.
Table  3  Glucose,  insulin  and  HOMA-IR  by  pubertal  stage  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage
(Tanner)
n  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  ×  mmol/L)
Average  %a p Average  %a p  Average  %a p
Prepubertal  16  83.5  ± 11.3  7.6 0.0388  10.6  ±  4.4 16.2  0.235  2.3  ± 1.3  21.3  0.1665
Middle pubertal  216  85.0  ± 12.1  10.9  0.0097  13.1  ±  10.3  5.1  0.4502  2.8  ± 2.4  44.7  0.182
Postpubertal 60  89.5  ± 9.7  14  0.0247* 14.3  ±  12.0  31.8  0.4398* 3.3  ± 3.0  52.3  0.2255*
a % of values above the cutoff point. Cutoff points: glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL,
postpubertal ≥20 mU/mL; HOMA-IR ≥3.16. For the value of  p we collated the pubertal with the postpubertal states (t-Student).
* ANOVA.
the  highest  values  in  females  occurred  in  the postpubertal
stage,  while in  males  the  highest  values  for  INS  and  HOMA-IR
occurred  in  the  pubertal  stage  and  the highest  values  for GL
occurred  in  the postpubertal  stage  (Table  4).
The  results  of each  of  the parameters  were  compared
with  each  pubertal  stage  by  gender;  we  found  that  there
were  no  statistically  significant  differences  in the  prepuber-
tal  stage,  while  in the  pubertal  stage  there  were  differences
in  GL  (p  ≤ 0.0001)  and  HOMA-IR  (p = 0.0408)  and  differences
in  INS  (p  = 0.0085)  and  HOMA-IR  (p  =  0.0101)  in the postpu-
bertal  stage  were  also  observed.
Mean  values  obtained  from  the three  biochemical  param-
eters  concerning  adolescents  without  COB  (76.4%)  were  GL
84.2  ± 11.4  mg/dL,  HOMA-IR  2.1  ± 1.5  with  8.5  and  24.2%
of  values  over  the cutoff  points,  respectively,  and  INS
9.9  ±  6.1  UI/mL.  For adolescents  with  COB  (23.6%),  GL
was  91.1  ± 11.2  mg/dL,  HOMA-IR  5.4 ±  3.4  with  21.3  and
74.4%  of  values  over the cutoff  points,  respectively,  and  INS
23.7  ± 14.2  UI/mL.  When  the  results  of  the three  biochem-
ical  parameters  of  adolescents  with  and  without  COB  were
compared,  there  were  statistically  significant  differences  in
all  three  parameters  (p ≤  0.0001).
Concerning  COB  prevalence  and  pubertal  stage,  it was
reported  that  6.7%  occurred  in the  prepubertal  stage,  22.2%
in  the  pubertal  stage  and  33.3%  in the postpubertal  stage.
When  the  results  of  the biochemical  parameters  were  asso-
ciated  with  pubertal  stage  and  waist  circumference,  it  was
noted  that  in all  pubertal  stages,  the  adolescents  who  dis-
played  COB  presented  higher  values,  observing  a high  IR
incidence  in  pubertal  and  postpubertal  stages  (Table  5).
When  performing  a  comparative  study  of the results  of
the  biochemical  parameters  in adolescents  with  and  without
COB  in  each  of  the pubertal  stages,  statistically  significant
differences  were  found  in  pubertal  stage  in  GL (p  ≤  0.0001),
INS  (p  ≤  0.0001)and  HOMA-IR  (p  ≤  0.0001).  There  were  no
significant  differences  in GL  (p  =  0.7171),  INS  (p  ≤  0.0001)
or  HOMA-IR  (p  ≤  0.0001)  in the postpubertal  stage.  When
comparing  the results  of  adolescents  with  COB  and  the
pubertal  and postpubertal  stages  there  were  no  significant
differences  in GL  (p  =  0.3061),  INS (p  = 0.8707)  or  HOMA-IR
(p  =  0.9734)  values.
The  result  of  the sensitivity  and  specificity  analysis
revealed  the fact  that  HOMA-IR  proved  to  be  a good  pre-
dictor  of  IR presence  (Fig.  1),  which  reflects  a higher
discriminating  power  in the evaluation  of  this syndrome.
Discussion
This  study  showed  an  elevated  prevalence  of  overweight-













Figure  1  The  area  below  the  ROC  curve  of  the  HOMA-IR  as  a
predictor of  insulin  resistance.










Table  4  Glucose,  insulin  and  HOMA-IR  by  pubertal  stage  (Tanner)  and  gender.  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage  (Tanner)  n  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  ×  mmol/L)
Average  %a p Average  %a p  Average  %a p
Female
Prepubertal 4  84.3  ±  10.4 8.2 ** 12.1  ±  5.2 30.3 ** 2.6  ±  1.4 35.3 **
Middle  pubertal 104  81.0  ±  10.6 3.7 <0.0001 12.1  ±  8.6 1.9 0.0133 2.5  ±  2.0 36.7 1
Postpubertal 44  89.0  ±  11.0 16 0.0003* 16.7  ±  13.1 40.1 0.0425 3.9  ±  3.3 59.2 0.9961*
Male
Prepubertal  12  83.3  ±  12.0  8.7  0--0014  10.1  ±  4.2  12.8  0.1196  2.2  ±  1.0  17.3  0.2276
Middle pubertal  112  88.7  ±  12.4  18  <0.0001  14.0  ±  11.6  8.5  0.325  3.2  ±  2.7  50  0.0379
Postpubertal 16  90.6  ±  4.9  3 <0.0001* 7.6  ±  3.9  0.1  0.0547* 1.7  ±  0.9  5.5  0.0557*
a % of values above the cutoff point. Cutoff points: Glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL, postpubertal ≥20 mU/mL; HOMA-IR ≥3.16. For
the value of p we collated the pubertal with the postpubertal states (t-Student).
* ANOVA.
** This statistic was not analyzed because of  the low  number of  n.
Table  5  Glucosa,  insulin  and  HOMA  by  pubertal  stage  (Tanner)  and  waist  circumference.  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage  (Tanner) PC  n Glucose  (mg/dL) Insulin  (UI/mL) HOMA-IR  (UI/mL  × mmol/L)
Average %a p  Average %a p  Average  %a p
Prepubertal  <90  15  82.5  ± 11.0  6  -- 10  ±  3.8  9.8  --  2.1  ±  0.9  13.3  --
>90 1 98  --  -- 19.6  --  --  4.7  -- --
Middle pubertal  <90  168 83.1  ± 11.9  7.7  <0.0001  10.1  ±  6.4  0.1  <0.0001  2.1  ±  1.4  23.2  <0.0001
>90 48  91.9  ± 10.7  22.5  23.6  ±  13.9  32.5  5.4  ±  3.3  75.3
Postpubertal <90  40  89.8  ± 8.2  10.7  0.7171  9.3  ±  5.3  2.3  <0.0001  2.9  ±  1.7  30.5  <0.0001
>90 20  88.8  ± 12.4  18.7  24.2  ±  15.3  60.8  5.4  ±  3.9  71.8
PC: waist percentile.
a % of values above the  cutoff point. Cutoff points: glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL, postpubertal ≥20 mU/mL; HOMA-IR ≥3.16.
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HOMA-IR  (46%).  These  results  were  higher  than  those
reported  in  adolescents  in the same  age  range  for  over-
weightness  (19%)  and  obesity  (13%)  in Chiapas,  Mexico,5
and  even  lower  than  those  reported  in adolescents  between
10  and  17  years  with  obesity  (49.2%)  in Lima,  Peru.1 As
expected,  adolescents  with  obesity  and central  obesity
showed  significantly  higher  INS and  HOMA-IR  numbers  com-
pared  to  those  adolescents  with  a  normal  BMIz.
In  this  manner,  the adolescents  without  obesity  mani-
fested  average  values  for  INS (8 UI/mL)  and  HOMA-IR  (1.8),
and  the  adolescents  with  obesity  had  averages  of  INS as
21.9  UI/mL  and  HOMA-IR  4.9.  We  would like  to  point out
the  fact  that  adolescents  with  morbid  obesity  reached  INS
levels  of  91.6  UI/mL  and  HOMA-IR  values  of 20.3,  values
never  before  reported  in the Mexican  population.  These  find-
ings  in  adolescents  of  both  genders  confirm  those  reported
by  other  authors  in  the sense  that  they  observed  a  posi-
tive  relationship  between  IR and the  presence  of  obesity
and  that  it  increases  progressively  in  function  of  the excess
of  weight.1,5--7,37
Regarding  basal GL levels,  this increased  as  BMIz
increased.  We  found that  the  average  levels  are  greater
in  males  than in  females,  just as reported  by  Souki-Rincón
et  al.22
Similar  to  other  studies  previously  conducted,  we  found
in  ours  that  INS concentrations  are higher  in  female  adoles-
cents  than  in  males.21 In  this  study,  approximately  2  out  of
every  10  adolescents  with  overweightness  and  7 out  of  10
with  obesity  displayed  IR,  the  male  gender  being  the most
affected.  A  significant  correlation  between  INS concentra-
tions  and  HOMA-IR  was  found,  which  was  expected,  because
HOMA-IR  values  are  derived  from  INS  and GL  concentrations.
Antropometric  measurements,  BMIz,  and  WC  are indepen-
dently  associated  with  GL,  INS and  HOMA-IR  levels.  We  were
able  to observe  that  WC  predicted  these  variables  more
accurately  in  comparison  to  BMIz.
Furthermore,  given  the fact  that  INS and  HOMA-IR  con-
centrations  followed  the  same  distribution,  we  were  able  to
consider  the latter  as  a  meter  to  be  as  good  as  basal  INS  to
establish  IR.  Keskin  et  al. showed  that  HOMA-IR  had a high
specificity  and  sensitivity  for  IR measurement  in children  and
adolescents.36
The  prevalence  of  IR found  in the studied  population
(46%)  exceeds  that reported  by  Acosta  et  al.7 These  authors
also  used  HOMA-IR  values  higher  than 3.1 for an IR diag-
nosis.  On the other  hand,  it was  found  that  approximately
half  of  the  adolescents  in  the  postpubertal  state  (IV  and
V)  displayed  higher  levels  of INS  and HOMA-IR.  When  ana-
lyzing  pubertal  stage  by  gender,  the  highest  values  of
chemical  parameters  were found  in females  in  the  post-
pubertal  (IV and V)  and  males  with  pubertal  stage  (II  and
III).  Rojas-Gabulli  et  al.1 suggested  that  IR,  which  results
in  hyperinsulinemia,  according  to Arslanian  and  Kalhan38
is observed  between  Tanner  stages  II  and  IV. These  results
agree  with  our  results.  Also,  IR  found  in the study’s  adoles-
cents  was  lower  than  that  reported  by  Kurtoglu  et  al.39 in
adolescents  in the  prepubertal  (male  37%  and  female  27.8%)
and  pubertal  stages  (male  61.7%  and  female  66.7%). These
differences  are  based  on  the fact  that  these  authors  utilized
different  reference  values  according  to  gender  and  sexual
maturation  stage  for  their  IR diagnosis,  using the follow-
ing  HOMA-IR  values:  for  the  prepubertal  stage  the following
values  were  used:  male  2.67  and  female  2.22,  and  for  the
pubertal  stage:  male  5.22  and  female  3.82.  Thus,  we  present
the  need  to  continue  conducting  studies  on  adolescents,
allowing  the establishment  of  normal  levels  for  INS  as  well  as
for  HOMA-IR.  The  highest  insulin  and  HOMA-IR  values  were
observed  in adolescents  with  COB.  Moreover,  the  incidence
of  higher  INS and  HOMA-IR  values  were observed  in adoles-
cents  with  COB  in the pubertal  and  postpubertal  stages,  like
other  authors.7,39 The  evaluation  of  HOMA-IR’s  ability  to  pre-
dict  an  IR diagnosis  through  the analysis  of  the ROC  curve,
indicates  that  it has  a high  sensitivity  and  specificity  for  this
purpose.
The  main  strengths  of this  study  are  the  homogeneity  of
the  conditions  at which  samples  were taken,  conducting  sim-
ple  non-invasive  studies  like  WC  (waist  circumference)  BMIz,
INS,  basal  GL  and  HOMA-IR,  and  HOMA-IR  being  a  high  sensi-
tivity  and  specificity  indicator.  The  limitations  of  this  study
are  the following:  since  it is  a  relatively  small demographic
sample,  it  was  not necessarily  a sample  representative  of
the  population  of  the  same  age  intervals  (however,  it  may
serve  for  comparison  of  other  Mexican  adolescents);  not
having  cutoff  points  in HOMA-IR  for  Mexican  adolescents  of
different  ages  and  pubertal  stages,  and  not  having  a  bal-
anced  representative  number  for  each  one of  the  pubertal
maturation  stages.
Conclusion
This  study  shows  a  high  OW,  OB and  COB  incidence.  It
revealed  a  positive  correlation  between  the  rise  in  GL,  INS
and HOMA-IR  levels  and  the rise  of  BMIz  and  COB,  showing  a
high  IR incidence.  Therefore,  OW,  OB,  COB  and  HOMA-IR  can
be  used  as  a  reference  in clinical  practice  for  IR diagnosis and
can  be significant  predictors  of  DM2.  These  data  highlight  the
importance  of  early  IR detection  in adolescents  with  OW,  OB,
and  COB,  and  stress  the importance  of  managing  early  inter-
vention  strategies,  which  allow  the  identification  of  IR  risk,
for its  timely  management  and prevention  of  DM2,  CVD  and
MS development.
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